About
Joined RiverVest and helped develop the firm's successful biopharma strategy.
Deals · 1
Genoa PharmaceuticalsBoard seat
via RiverVest Venture Partners · filed Oct 2023 · $189.2M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at RiverVest Venture Partners
Alessandro Sette
Scientific Advisor; Professor and Member, La Jolla Institute for Immunology at RiverVest Venture Partners
Andrew Kleiboeker
Associate at RiverVest Venture Partners
Andy Craig
Co-founder at RiverVest Venture Partners
Corrin Short
Executive Assistant at RiverVest Venture Partners
Courtney Harris
Controller at RiverVest Venture Partners
Derek Rapp
Investor at RiverVest Venture Partners
Gary DeCrescenzo
Scientific Advisor; Independent Consultant, Pharmaceutical Research and Development at RiverVest Venture Partners
Isaac Zike
Managing Director, Ph.D. at RiverVest Venture Partners